Effects of early, abrupt weaning on HIV-free survival of children in Zambia.

Louise Kuhn, Grace M Aldrovandi, Moses Sinkala, Chipepo Kankasa, Katherine Semrau, Mwiya Mwiya, Prisca Kasonde, Nancy Scott, Cheswa Vwalika, Jan Walter, Marc Bulterys, Wei-Yann Tsai, Donald M Thea, Zambia Exclusive Breastfeeding Study
Author Information
  1. Louise Kuhn: Gertrude H. Sergievsky Center and the Department of Epidemiology, Mailman School of Public Health, Columbia University, New York 10032, USA. lk24@columbia.edu

Abstract

BACKGROUND: In low-resource settings, many programs recommend that women who are infected with the human immunodeficiency virus (HIV) stop breast-feeding early. We conducted a randomized trial to evaluate whether abrupt weaning at 4 months as compared with the standard practice has a net benefit for HIV-free survival of children.
METHODS: We enrolled 958 HIV-infected women and their infants in Lusaka, Zambia. All the women planned to breast-feed exclusively to 4 months; 481 were randomly assigned to a counseling program that encouraged abrupt weaning at 4 months, and 477 to a program that encouraged continued breast-feeding for as long as the women chose. The primary outcome was either HIV infection or death of the child by 24 months.
RESULTS: In the intervention group, 69.0% of the mothers stopped breast-feeding at 5 months or earlier; 68.8% of these women reported the completion of weaning in less than 2 days. In the control group, the median duration of breast-feeding was 16 months. In the overall cohort, there was no significant difference between the groups in the rate of HIV-free survival among the children; 68.4% and 64.0% survived to 24 months without HIV infection in the intervention and control groups, respectively (P=0.13). Among infants who were still being breast-fed and were not infected with HIV at 4 months, there was no significant difference between the groups in HIV-free survival at 24 months (83.9% and 80.7% in the intervention and control groups, respectively; P=0.27). Children who were infected with HIV by 4 months had a higher mortality by 24 months if they had been assigned to the intervention group than if they had been assigned to the control group (73.6% vs. 54.8%, P=0.007).
CONCLUSIONS: Early, abrupt cessation of breast-feeding by HIV-infected women in a low-resource setting, such as Lusaka, Zambia, does not improve the rate of HIV-free survival among children born to HIV-infected mothers and is harmful to HIV-infected infants.(ClinicalTrials.gov number, NCT00310726.)

Associated Data

ClinicalTrials.gov | NCT00310726

References

  1. AIDS. 2006 Jul 13;20(11):1539-47 [PMID: 16847409]
  2. J Acquir Immune Defic Syndr. 2002 Nov 1;31(3):331-8 [PMID: 12439210]
  3. J Infect Dis. 2004 Jun 15;189(12):2149-53 [PMID: 15181560]
  4. N Engl J Med. 1991 Aug 29;325(9):593-8 [PMID: 1812850]
  5. Pediatrics. 2005 Feb;115(2):496-506 [PMID: 15687461]
  6. JAMA. 2006 Aug 16;296(7):782-93 [PMID: 16905784]
  7. J Infect Dis. 2004 Jun 15;189(12):2154-66 [PMID: 15181561]
  8. JAMA. 1999 Aug 25;282(8):744-9 [PMID: 10463709]
  9. Lancet Infect Dis. 2003 Dec;3(12):786-93 [PMID: 14652204]
  10. Am J Clin Nutr. 2007 Feb;85(2):635S-638S [PMID: 17284769]
  11. AIDS. 2005 Aug 12;19(12):1309-15 [PMID: 16052086]
  12. AIDS. 2001 Feb 16;15(3):379-87 [PMID: 11273218]
  13. Am J Public Health. 1997 Jun;87(6):926-31 [PMID: 9224171]
  14. J Pediatr. 1991 May;118(5):659-66 [PMID: 2019919]
  15. Lancet. 1997 Apr 12;349(9058):1054-9 [PMID: 9107243]
  16. JAMA. 2001 Nov 21;286(19):2413-20 [PMID: 11712936]
  17. J Infect Dis. 2007 Jan 15;195(2):165-7 [PMID: 17191159]
  18. AIDS. 2005 Apr 29;19(7):699-708 [PMID: 15821396]
  19. JAMA. 2006 Aug 16;296(7):794-805 [PMID: 16905785]
  20. J Infect Dis. 1996 Oct;174(4):722-6 [PMID: 8843208]
  21. AIDS. 2000 Nov 10;14(16):2535-41 [PMID: 11101065]
  22. Lancet. 2000 Feb 5;355(9202):451-5 [PMID: 10841125]
  23. Control Clin Trials. 2004 Aug;25(4):353-65 [PMID: 15296810]
  24. Nutr Rev. 2001 Apr;59(4):119-27 [PMID: 11368506]
  25. JAMA. 2007 Oct 24;298(16):1888-99 [PMID: 17954540]
  26. JAMA. 2000 Mar 1;283(9):1167-74 [PMID: 10703779]
  27. J Clin Microbiol. 2003 Jun;41(6):2465-70 [PMID: 12791866]
  28. AIDS. 2003 Jun 13;17(9):1377-82 [PMID: 12799559]
  29. Lancet. 2007 Mar 31;369(9567):1107-16 [PMID: 17398310]
  30. AIDS. 1998 Nov 12;12(16):2211-6 [PMID: 9833863]
  31. J Infect Dis. 2006 Dec 1;194(11):1510-8 [PMID: 17083035]
  32. J Nutr. 2005 May;135(5):1113-9 [PMID: 15867290]
  33. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Feb 1;8(2):176-81 [PMID: 7834399]

Grants

  1. D43 TW001035-09/FIC NIH HHS
  2. R01 HD039611/NICHD NIH HHS
  3. R01 HD 39611/NICHD NIH HHS
  4. R01 HD040777/NICHD NIH HHS
  5. R01 HD 40777/NICHD NIH HHS
  6. D43 TW001035/FIC NIH HHS

MeSH Term

Anti-Retroviral Agents
Breast Feeding
Disease-Free Survival
Female
HIV
HIV Infections
Humans
Infant
Infant Mortality
Infectious Disease Transmission, Vertical
Kaplan-Meier Estimate
Lymphocyte Count
Male
Patient Compliance
Statistics, Nonparametric
Weaning
Zambia

Chemicals

Anti-Retroviral Agents

Word Cloud

Created with Highcharts 10.0.0monthswomenHIVbreast-feeding4HIV-freesurvivalabruptweaningchildrenHIV-infected24interventiongroupcontrolgroupsinfectedinfantsZambiaassignedP=0low-resourceearlyLusakaprogramencouragedinfection0%mothers688%significantdifferencerateamongrespectivelyBACKGROUND:settingsmanyprogramsrecommendhumanimmunodeficiencyvirusstopconductedrandomizedtrialevaluatewhethercomparedstandardpracticenetbenefitMETHODS:enrolled958plannedbreast-feedexclusively481randomlycounseling477continuedlongchoseprimaryoutcomeeitherdeathchildRESULTS:69stopped5earlierreportedcompletionless2daysmedianduration16overallcohort4%64survivedwithout13Amongstillbreast-fed839%807%27Childrenhighermortality736%vs54007CONCLUSIONS:EarlycessationsettingimprovebornharmfulClinicalTrialsgovnumberNCT00310726Effects

Similar Articles

Cited By